战略愿景满足技术严谨:Deepaben Bhavsar领导高股东IND获得FDA批准

by

2025/07/22

featured image - 战略愿景满足技术严谨:Deepaben Bhavsar领导高股东IND获得FDA批准

人工智能驱动的催化剂仪表板:迪佩什·卡什夫如何恢复了32亿美元的网络业务

打破ServiceNow实施的新基础:Deeksha Sivakumer的CSM成功故事

About Author

Sanya Kapoor@sanya_kapoor

Expert Tech writer and Reporter

Read my stories 學到更多

註釋

標籤

management #ind-fda-approval #deepaben-bhavsar #clinical-study-report-(csr)#regulatory-submissions #chronic-kidney-disease-drug #ectd-document-management #fda-compliance #good-company

这篇文章刊登在

Terminal

Lite

Related Stories